Vigil Neuroscience, Inc. (VIGL)
USD 1.65
(-4.62%)
USD 1.65
(-4.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -70.36 Million | -65.14 Million | -39.34 Million | -5.18 Million |
| Net Income | -82.63 Million | -68.3 Million | -43.28 Million | -28.54 Million |
| Depreciation & Amortization | 399 Thousand | 78 Thousand | 28 Thousand | - |
| Deferred income taxes | -5000.00 | - | - | - |
| Stock-based compensation | 8.9 Million | 5.47 Million | 2.08 Million | 524.00 |
| Change in working capital | 3.09 Million | -3.33 Million | 642 Thousand | 850 Thousand |
| Other non-cash items | -120 Thousand | 932 Thousand | 1.18 Million | 21.4 Million |
| Investing Cash Flow | -65.13 Million | -921 Thousand | -204 Thousand | -500 Thousand |
| Investments in PPE | -674 Thousand | -921 Thousand | -204 Thousand | -500 Thousand |
| Acquisitions | 64.46 Thousand | - | - | - |
| Investment purchases | -147.46 Million | - | - | - |
| Sales/Maturities of investments | 83 Million | - | - | - |
| Other Investing Activities | -64.46 Thousand | - | - | -1000.00 |
| Financing Cash Flow | 888 Thousand | 161.25 Million | 107.74 Million | 29.83 Million |
| Debt repayment | -23 Thousand | -43 Thousand | -38 Thousand | -5 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 911 Thousand | 140.46 Million | 19.87 Million | 24.83 Million |
| Other Financing Activities | 911 Thousand | 20.83 Million | 87.9 Million | 59.66 Thousand |
| Accounts receivables | - | - | - | - |
| Accounts payables | 5000.00 | -2.47 Million | 2.35 Million | 1.1 Million |
| Inventory | - | - | - | - |
| Other working capital | 3.09 Million | -853 Thousand | -1.7 Million | -257 Thousand |
| Cash at beginning of period | 186.6 Million | 92.34 Million | 24.15 Million | - |
| Cash at end of period | 51.99 Million | 187.53 Million | 92.34 Million | 24.15 Million |
| Capital Expenditure | -674 Thousand | -921 Thousand | -204 Thousand | -500 Thousand |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -134.61 Million | 95.18 Million | 68.19 Million | 24.15 Million |
| Free Cash Flow | -71.03 Million | -66.07 Million | -39.55 Million | -5.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.22 Million | -19.94 Million | -22.17 Million | -82.63 Million | -20.49 Million | -20.17 Million |
| Depreciation & Amortization | 113 Thousand | 113 Thousand | 113 Thousand | 399 Thousand | 110 Thousand | 111 Thousand |
| Deferred income taxes | - | - | -2.06 Million | -5000.00 | -772 Thousand | -756 Thousand |
| Stock-based compensation | 2.7 Million | 2.31 Million | 2.48 Million | 8.9 Million | 2.42 Million | 2.25 Million |
| Change in working capital | 3.08 Million | -4.28 Million | 3.44 Million | 3.09 Million | 1.07 Million | 2.84 Million |
| Other non-cash items | 2.84 Million | 2.91 Million | 2.69 Million | -120 Thousand | 342 Thousand | 363 Thousand |
| Investing Cash Flow | 1.04 Million | 16.46 Million | 10.65 Million | -65.13 Million | 15.31 Million | -22.1 Million |
| Investments in PPE | -5000.00 | - | -13 Thousand | -674 Thousand | -47 Thousand | -122 Thousand |
| Acquisitions | - | - | -10.66 Thousand | 64.46 Thousand | -15.36 Thousand | -12 Million |
| Investment purchases | -30.84 Million | - | -30.33 Million | -147.46 Million | -14.63 Million | -33.98 Million |
| Sales/Maturities of investments | 31.89 Million | 16.46 Million | 41 Million | 83 Million | 30 Million | 12 Million |
| Other Investing Activities | 1049.00 | 16.46 Thousand | 10.66 Thousand | -64.46 Thousand | 15.36 Thousand | 12 Million |
| Financing Cash Flow | 9000.00 | 5.18 Million | 53 Thousand | 888 Thousand | 53 Thousand | 579 Thousand |
| Debt repayment | - | - | - | -23 Thousand | -2000.00 | -10 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9000.00 | 5.18 Million | 53 Thousand | 911 Thousand | 55 Thousand | 589 Thousand |
| Other Financing Activities | 9.00 | 5184.00 | 53.00 | 911 Thousand | 55.00 | 579.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -92 Thousand | -455 Thousand | 644 Thousand | 5000.00 | -1.05 Million | 205 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.17 Million | -3.83 Million | 2.79 Million | 3.09 Million | 2.13 Million | 2.64 Million |
| Cash at beginning of period | 51.76 Million | 51.99 Million | 56.79 Million | 186.6 Million | 59.66 Million | 96.54 Million |
| Cash at end of period | 37.31 Million | 51.76 Million | 51.99 Million | 51.99 Million | 57.72 Million | 59.66 Million |
| Capital Expenditure | -5000.00 | - | -13 Thousand | -674 Thousand | -47 Thousand | -122 Thousand |
| Effect of forex changes on cash | - | - | -39.13 Million | - | - | 39.13 Million |
| Net cash flow / Change in cash | -14.44 Million | -231 Thousand | -4.8 Million | -134.61 Million | -1.94 Million | -36.87 Million |
| Free Cash Flow | -15.5 Million | -21.88 Million | -15.52 Million | -71.03 Million | -17.36 Million | -15.47 Million |
300820
4113
GWSAF
DAY
8012
EQR